000 01403 a2200349 4500
005 20250513202557.0
264 0 _c20000301
008 200003s 0 0 ger d
022 _a0723-5003
024 7 _a10.1007/BF03044976
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchott, M
245 0 0 _a[Drug therapy of endocrine neoplasms. Part I: Thyroid neoplasms, adrenal neoplasms and parathyroid neoplasms].
_h[electronic resource]
260 _bMedizinische Klinik (Munich, Germany : 1983)
_cJan 2000
300 _a20-5 p.
_bdigital
500 _aPublication Type: English Abstract; Journal Article; Review
650 0 4 _aAdrenal Gland Neoplasms
_xdrug therapy
650 0 4 _aAntineoplastic Agents, Hormonal
_xadministration & dosage
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadministration & dosage
650 0 4 _aGermany
_xepidemiology
650 0 4 _aHumans
650 0 4 _aIncidence
650 0 4 _aMitotane
_xadministration & dosage
650 0 4 _aOctreotide
_xadministration & dosage
650 0 4 _aParathyroid Neoplasms
_xdrug therapy
650 0 4 _aPheochromocytoma
_xdrug therapy
650 0 4 _aThyroid Neoplasms
_xdrug therapy
700 1 _aScherbaum, W A
700 1 _aFeldkamp, J
773 0 _tMedizinische Klinik (Munich, Germany : 1983)
_gvol. 95
_gno. 1
_gp. 20-5
856 4 0 _uhttps://doi.org/10.1007/BF03044976
_zAvailable from publisher's website
999 _c10622783
_d10622783